Login / Signup

Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea.

Kazuno OmoriHiroshi NomotoAkinobu NakamuraTakahiro TakaseKyu Yong ChoKota OnoNaoki MandaYoshio KuriharaShin AokiTatsuya AtsumiHideaki Miyoshi
Published in: Journal of diabetes investigation (2018)
Switching from SU to Repa improved GA and GA/HbA1c, and had favorable effects on glucose fluctuation in elderly patients with type 2 diabetes.
Keyphrases
  • pet ct
  • middle aged
  • blood glucose
  • community dwelling
  • metabolic syndrome
  • skeletal muscle
  • insulin resistance
  • weight loss
  • glycemic control